临床指南：呼吸科-2017 TSANZ立场声明：特发性肺纤维化的治疗.pdfVIP

POSITION STATEMENT Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of * Australia and New Zealand and the Lung Foundation Australia HELEN E. JO,1,2 LAUREN K. TROY,1,2 GREGORY KEIR,3 DANIEL C. CHAMBERS,4 ANNE HOLLAND,5 NICOLE GOH,4,7 MARGARET WILSHER,8 SALLY DE BOER,8 YUBEN MOODLEY,9 CHRISTOPHER GRAINGE,10 HELEN WHITFORD,6 SALLY CHAPMAN,11 PAUL N. REYNOLDS,11 IAN GLASPOLE,6 DAVID BEATSON,12 LEONIE JONES,10 PETER HOPKINS4 AND TAMERA J. CORTE1,2 1Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW; 2Faculty of Medicine, University of Sydney, Sydney, NSW; 3 Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD; 4 Department of Respiratory Medicine, The Prince Charles Hospital, Brisbane, QLD; 5Department of Physiotherapy, The Alfred Hospital, Melbourne, VIC; 6Department of Respiratory Medicine, The Alfred Hospital, Melbourne, VIC; 7 Department of Respiratory Medicine, Austin Hospital, Melbourne, VIC; 9Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, WA; 10Department of Respiratory Medicine, John Hunter Hospital, Newcastle, NSW; 11Department of Respiratory Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia; 8 Department of Respiratory Medicine, Auckland District Health Board, Auckland; 12Patient Advocate, Auckland, New Zealand ABSTRACT Abbreviations: 6MWD, 6-min walk distance; 6MWT, 6-min